Aspire Biopharma Begins Production of Pre-Workout Supplement

Aspire Biopharma Holdings, Inc. has announced the start of initial production of a new single-dose pre-workout supplement. The company collaborates with Desert Stream Inc. for this endeavor. Aspire plans to conduct consumer and safety testing in the second quarter of 2025. The supplement will feature Aspire's patent-pending sublingual delivery technology.

The product will contain 100mg of caffeine and beta-alanine to boost energy and mental focus. Aspire aims to release the supplement in three flavors and launch in specialty retail outlets in 2025. Packaged in convenient sachets, it eliminates the need for water, offering athletes and fitness enthusiasts ease of use.

The globally rising demand for pre-workout supplements is driven by increasing health awareness and expanding fitness centers. Aspire's CEO, Kraig Higginson, emphasized the potential of their sublingual delivery method to optimize caffeine control.